Information for Healthcare Professionals

Revised: 26 October 2018

This section provides information useful to healthcare professionals.

Medsafe Advice

Date Type Title
26 October 2018 Monitoring Communication M² Logo Possible risk of lichen planus or lichenoid drug eruption with zoster (shingles) vaccine or influenza vaccine
25 October 2018 Committee Medicines Adverse Reaction Committee - 175th meeting - 13 September 2018
8 October 2018 Compliance Sale of medicines and medical devices via social media
8 October 2018 Devices Surgical Mesh Implants - Implementation of Government Response to Report of the Health Committee on Petition 2011/102
5 October 2018 Committee Medicines Adverse Reaction Committee - Vacancy
27 September 2018 Recall Coaguchek (PDF 559 KB, 8 pages)
25 September 2018 Safety Alert Volulyte and Voluven (PDF 821 KB, 2 pages)
25 September 2018 Device Surgical Mesh Implants - Overseas Actions and Reviews
25 September 2018 Device Surgical Mesh Implants - Actions taken by Medsafe (2009 added)
6 September 2018 Publications Prescriber Update - September 2018
5 September 2018 Device The USFDA Warns Against Use of Energy-Based Devices to Perform Vaginal 'Rejuvenation' or Vaginal Cosmetic Procedures: FDA Safety Communication
30 August 2018 Committees Medicines Adverse Reactions Committee - Agenda for the 175th  meeting - 13 September 2018
14 August 2018 Monitoring Communication M² Logo Isotretinoin and Obsessive Compulsive Disorder (OCD)
13 August 2018 Alert Communication Codeine – new restrictions on use in children and young adults
9 August 2018 Committees Medicines Adverse Reactions Committee - Vacancies
7 August 2018 Surgical Mesh Adverse Event Reports relating to Surgical Mesh Implants dated August 2018 (PDF 16 pages, 294KB)
7 August 2018 Surgical Mesh All the surgical mesh information has been moved to a new surgical mesh area with a new Landing Page
6 August 2018 Alert Communication Dolutegravir and the possible risk of neural tube defects when taken early in pregnancy
27 July 2018 Medicine Consumer Level Recall - Melatonin 3mg tablets
8 June 2018 Publications Prescriber Update June 2018 Vol. 39 No. 2
25 May 2018 Consultations Review of fees payable under the Medicines Regulations 1984 - Outcome of Consultation
9 May 2018 Monitoring Communication Life-threatening severe allergic reaction (anaphylaxis) to Calocurb dietary supplement
30 April 2018 Monitoring Communication Beware turmeric/curcumin containing products can interact with warfarin
18 April 2018 Alert Communication Consumer Level Recall - Apo-Primidone 250mg tablets
18 April 2018 Committees

Education and Information

How medicines are classified, guidance for natural health practitioners and data sheets.


Safety related information on medicines and medical devices including recalls, early warnings and adverse reactions.


Healthcare professionals responsibilities with regard to the use of medicines and medical devices on patients.

ADR eLearning Module

Endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for around 1.0 hours CME for General Practice Educational Programme 2/3 (GPEP) and Continuing Professional Development (CPD) purposes.

Social media campaign raises awareness of ADR reporting
Uppsala Monitoring Centre teamed up with medicine regulatory authorities in 27 countries to launch a social media awareness campaign on the importance of reporting adverse drug reactions. (Thank you to the “Uppsala Monitoring Centre, Uppsala Reports 78” for this article.  The full issue can be found here -

If you have an enquiry that is not answered by the information on the web site please contact us at

You can subscribe to receive Prescriber Update emails.
You can also subscribe to receive a list of changes to Medsafe's web site by email.